Author

Shaheed Vally Omar

South African Medical Research CouncilPrimary ORCID profile (0000-0001-6983-1636 · 6 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Shaheed Vally OmariD6 papers · National Health Laboratory Service

Biology Disciplines

Click to filter author papers

Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Claudia SpiesiD· 1 shared David M. EngelthaleriD· 1 shared Frik A. Sirgel· 1 shared Grant TheroniD· 1 shared John Z. MetcalfeiD· 1 shared Marianna de KockiD· 1 shared Megan FolkertsiD· 1 shared Nabila A. IsmailiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

Claudia SpiesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Unpacking bedaquiline hetero-resistance: the importance of intermediate profiles for phenotypic drug-susceptibility testing

Nabila A. Ismail, Frik A. Sirgel, Shaheed Vally Omar, Shatha Omar, Marianna de Kock, Claudia Spies, Megan Folkerts, Grant Theron, David M. Engelthaler, John Z. Metcalfe, Robin M. Warren

This paper shows that considering intermediate results in phenotypic drug susceptibility testing can detect bedaquiline heteroresistance at low frequencies, improving resistance determination.

Antimicrobial Agents and Chemotherapy · Jul 21, 2025Peer-reviewedMicrobiology